MIPS #143 Pain Intensity Quantified
2025: no changes from 2024.
MEASURE DESCRIPTION
Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified.
Numerator
Numerator 1: Patient visits in which pain intensity is quantified
Numerator 2: Patient visits in which pain intensity is quantified
Numerator Instructions: Pain intensity should be quantified using a standard instrument, such as a 0-10 numerical rating scale, visual analog scale, a categorical scale, or pictorial scale.
Denominator
Denominator 1: All EM visits with cancer diagnosis receiving at least 2 chemotherapy admins on or within 30 days prior or 30 day after EM visit
Denominator 2: All radiation treatment visits (77427, 77431, 77432, 77435) visits with cancer diagnosis receiving radiation therapy
*Note: Practice Insights collects data for the eCQM version of MIPS 143, this means both oral and IV chemotherapy patients are included in the denominator. This is different from the CQM version; note that EOM4a is the CQM version.
Denominator Exclusion
None
Numerator Exclusion
None
Scoring
1-10 points
Patients undergoing hormone only treatment are not included in the denominator.
RESOURCES